ID

14340

Description

Efficacy and Safety of Ciclesonide (CIC) Administered Twice Daily in Pediatric Patients With Asthma.; ODM derived from: https://clinicaltrials.gov/show/NCT00392288

Link

https://clinicaltrials.gov/show/NCT00392288

Keywords

Versions (1)
  1. 4/11/16 4/11/16 -
Copyright Holder

CC BY-NC 3.0

Uploaded on

April 11, 2016

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Asthma NCT00392288

English

Eligibility Asthma NCT00392288

1 forms  
  1. StudyEvent: Eligibility
    1. Eligibility Asthma NCT00392288
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
history of persistent bronchial asthma for at least 3 months prior to screening;
Description

persistent asthma

Data type

boolean

Alias
UMLS CUI [1,1]
C3266628
UMLS CUI [1,2]
C0040223
for patients with persistent bronchial asthma and being treated with a controller therapy: documented use of an inhaled steroid or singulair® 5mg once daily;
Description

inhaled steroid or singulair

Data type

boolean

Alias
UMLS CUI [1]
C2065041
UMLS CUI [2]
C0595724
for patients with persistent bronchial asthma and not being treated with controller therapy: patients may have documented use of a reliever therapy such as albuterol/salbutamol or may be untreated;
Description

albuterol/salbutamol

Data type

boolean

Alias
UMLS CUI [1]
C0001927
morning peak expiratory flow (am pef) of ≤90% of predicted values from the in-clinic spirometry after a 6 hour withhold of albuterol/salbutamol;
Description

am pef

Data type

boolean

Alias
UMLS CUI [1,1]
C0030735
UMLS CUI [1,2]
C0332170
UMLS CUI [2]
C0001927
only patients aged between 6 to <12 years must have a forced expiratory volume in one second (fev1) of ≥50% to ≤85% of predicted normal after a 6 hour withhold of albuterol/salbutamol
Description

fev1

Data type

boolean

Alias
UMLS CUI [1]
C0748133
UMLS CUI [2]
C0001927
UMLS CUI [3]
C0001779
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
nocturnal awakenings for asthma which require treatment with albuterol/salbutamol for 4 or more nights out of the last 7 days of the screening period;
Description

nocturnal awakenings

Data type

boolean

Alias
UMLS CUI [1]
C0860510
UMLS CUI [2]
C0004096
UMLS CUI [3]
C0001927
use of more than 8 puffs/day of albuterol/salbutamol on 3 or more consecutive days within the last 7
Description

more than 8 puffs/day of albuterol/salbutamol

Data type

boolean

Alias
UMLS CUI [1,1]
C0001927
UMLS CUI [1,2]
C3476109
upper or lower respiratory tract infection within 4 weeks prior to screening and during screening period;
Description

respiratory tract infection

Data type

boolean

Alias
UMLS CUI [1,1]
C0035243
UMLS CUI [1,2]
C0040223
history of life-threatening asthma, including a history of significant hypercarbia (pco2 >45 mmhg), prior intubation, respiratory arrest, or seizures as a result of an exacerbation of asthma;
Description

life-threatening asthma

Data type

boolean

Alias
UMLS CUI [1,1]
C0004096
UMLS CUI [1,2]
C2826244
UMLS CUI [2]
C0020440
UMLS CUI [3]
C0021925
UMLS CUI [4]
C0349790
UMLS CUI [5]
C0162297
more than 3 in-patient hospitalization or emergency care visits due to asthma exacerbations in the year prior to screening;
Description

hospitalization or emergency care

Data type

boolean

Alias
UMLS CUI [1]
C0019993
UMLS CUI [2]
C0349790
UMLS CUI [3]
C1527398
use of injectable or oral corticosteroids within one month prior to screening, or more than 3 bursts) within 6 months prior to screening;
Description

corticosteroids

Data type

boolean

Alias
UMLS CUI [1,1]
C0001617
UMLS CUI [1,2]
C0040223
Back to the top of the page

Similar models

Eligibility Asthma NCT00392288

1 forms
  1. StudyEvent: Eligibility
    1. Eligibility Asthma NCT00392288
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
persistent asthma
Item
history of persistent bronchial asthma for at least 3 months prior to screening;
boolean
C3266628 (UMLS CUI [1,1])
C0040223 (UMLS CUI [1,2])
inhaled steroid or singulair
Item
for patients with persistent bronchial asthma and being treated with a controller therapy: documented use of an inhaled steroid or singulair® 5mg once daily;
boolean
C2065041 (UMLS CUI [1])
C0595724 (UMLS CUI [2])
albuterol/salbutamol
Item
for patients with persistent bronchial asthma and not being treated with controller therapy: patients may have documented use of a reliever therapy such as albuterol/salbutamol or may be untreated;
boolean
C0001927 (UMLS CUI [1])
am pef
Item
morning peak expiratory flow (am pef) of ≤90% of predicted values from the in-clinic spirometry after a 6 hour withhold of albuterol/salbutamol;
boolean
C0030735 (UMLS CUI [1,1])
C0332170 (UMLS CUI [1,2])
C0001927 (UMLS CUI [2])
fev1
Item
only patients aged between 6 to <12 years must have a forced expiratory volume in one second (fev1) of ≥50% to ≤85% of predicted normal after a 6 hour withhold of albuterol/salbutamol
boolean
C0748133 (UMLS CUI [1])
C0001927 (UMLS CUI [2])
C0001779 (UMLS CUI [3])
Item Group
C0680251 (UMLS CUI)
nocturnal awakenings
Item
nocturnal awakenings for asthma which require treatment with albuterol/salbutamol for 4 or more nights out of the last 7 days of the screening period;
boolean
C0860510 (UMLS CUI [1])
C0004096 (UMLS CUI [2])
C0001927 (UMLS CUI [3])
more than 8 puffs/day of albuterol/salbutamol
Item
use of more than 8 puffs/day of albuterol/salbutamol on 3 or more consecutive days within the last 7
boolean
C0001927 (UMLS CUI [1,1])
C3476109 (UMLS CUI [1,2])
respiratory tract infection
Item
upper or lower respiratory tract infection within 4 weeks prior to screening and during screening period;
boolean
C0035243 (UMLS CUI [1,1])
C0040223 (UMLS CUI [1,2])
life-threatening asthma
Item
history of life-threatening asthma, including a history of significant hypercarbia (pco2 >45 mmhg), prior intubation, respiratory arrest, or seizures as a result of an exacerbation of asthma;
boolean
C0004096 (UMLS CUI [1,1])
C2826244 (UMLS CUI [1,2])
C0020440 (UMLS CUI [2])
C0021925 (UMLS CUI [3])
C0349790 (UMLS CUI [4])
C0162297 (UMLS CUI [5])
hospitalization or emergency care
Item
more than 3 in-patient hospitalization or emergency care visits due to asthma exacerbations in the year prior to screening;
boolean
C0019993 (UMLS CUI [1])
C0349790 (UMLS CUI [2])
C1527398 (UMLS CUI [3])
corticosteroids
Item
use of injectable or oral corticosteroids within one month prior to screening, or more than 3 bursts) within 6 months prior to screening;
boolean
C0001617 (UMLS CUI [1,1])
C0040223 (UMLS CUI [1,2])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial